Market Overview

Diabetes Devices Market Analysis 2018 By Device Type (Self-monitoring & Diagnostic Devices), Delivery Type (Syringes, Pumps, Pens, Injectors) And Segment Forecasts To 2024 - ResearchAndMarkets.com

Share:

The "Diabetes
Devices Market Analysis By Device Type (Self-monitoring & Diagnostic
Devices (Lancets, Analog Glucose Meter, Continuous Glucose Monitor &
Test Strips)), Delivery Type (Syringes, Pumps, Pens, Injectors) And
Segment Forecasts To 2024"
report has been added to ResearchAndMarkets.com's
offering.

The global diabetes devices market size is expected to reach USD 35.5
billion by 2024

The market is projected to expand at a CAGR of 7.0% during the forecast
period. Growing cases of diabetes, due to obesity, sedentary and
unhealthy lifestyles, and several other factors, is expected to drive
demand for diabetes devices over the next few years.

Obesity is believed to be one of the foremost factors leading to
diabetes in individuals. According to WHO, in 2014, over 1.9 billion
people were identified to be overweight, of which, around 600 million
people were obese.

Some of the key companies in the global diabetes devices market are
Medtronic PLC, Sanofi S.A., Bayer Healthcare AG, Becton, Dickinson and
Company, Novo Nordisk A/S, Abbott Laboratories, F. Hoffman-La Roche AG,
and Johnson & Johnson.

Further key findings from the study suggest:

  • Constantly rising target population base is the primary factor driving
    market growth
  • Test strips captured the largest share in the monitoring and
    diagnostics device segment while insulin pens accounted for the
    largest revenue share among insulin delivery devices in 2016. This can
    be attributed to rapid adoption of these user-friendly, quick, and
    accurate devices for homecare use
  • North America is leading the regional market, followed by Europe.
    Advanced healthcare infrastructure and availability of technologically
    advanced products have driven the regional market

Key Topics Covered:

Chapter 1 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Industry Outlook

Chapter 4 Diabetes Devices Market: Product Estimates & Trend Analysis

Chapter 6 Diabetes Devices Market: Regional Estimates & Trend Analysis,
by Product and End-Use

Chapter 7 Competitive Landscape

  • Abbott Laboratories Inc.
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Bayer Healthcare AG
  • Becton, Dickinson and Company
  • Medtronic
  • Novo Nordisk A/S
  • Sanofi

For more information about this report visit https://www.researchandmarkets.com/research/whfnjn/diabetes_devices?w=4

View Comments and Join the Discussion!